(Q30860458)

27 June 2017

1 reference

title

Pharmacological therapy for glaucoma: a review (English)

1 reference

27 June 2017

1 reference

Hoyng PF

1

1 reference

PubMed ID

10776828

27 June 2017

van Beek LM

series ordinal

2

1 reference

27 June 2017

1 March 2000

1 reference

27 June 2017

1 reference

27 June 2017

59

1 reference

27 June 2017

3

1 reference

27 June 2017

411-434

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200059030-00003

27 June 2017

0 references

cites work

A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group.

1 reference

12 December 2020

Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage

1 reference

12 December 2020

Apraclonidine. A one-week dose-response study

1 reference

12 December 2020

Association between intraocular pressure and loss of visual field in chronic simple glaucoma

1 reference

12 December 2020

Hematologic reactions to carbonic anhydrase inhibitors

1 reference

12 December 2020

Effect of topical apraclonidine on the frequency of intraocular pressure elevations after combined extracapsular cataract extraction and trabeculectomy

1 reference

12 December 2020

Timolol, dose response and duration of action

1 reference

12 December 2020

Dipivalyl epinephrine: a new pro-drug in the treatment of glaucoma

1 reference

12 December 2020

Latanoprost. Two years' experience of its use in the United Kingdom. Latanoprost Study Group.

1 reference

12 December 2020

[Origin of ocular hypertension in primary glaucoma.]

1 reference

12 December 2020

Levobunolol vs timolol for open-angle glaucoma and ocular hypertension

1 reference

12 December 2020

Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol

1 reference

12 December 2020

Models of open-angle glaucoma prevalence and incidence in the United States.

1 reference

12 December 2020

Ocular carteolol. A review of its pharmacological properties, and therapeutic use in glaucoma and ocular hypertension

1 reference

12 December 2020

PhXA34, a new potent ocular hypotensive drug. A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers

1 reference

12 December 2020

A 90-day study of the efficacy and side effects of 0.25% and 0.5% apraclonidine vs 0.5% timolol. Apraclonidine Primary Therapy Study Group.

1 reference

12 December 2020

A repeated dose-response study of methazolamide in glaucoma

1 reference

12 December 2020

Metipranolol associated granulomatous anterior uveitis: not so uncommon as thought

1 reference

12 December 2020

Effects of long-term treatment with timolol on lacrimal gland function

1 reference

12 December 2020

Effects of topical application of UF-021, a novel prostaglandin derivative, on aqueous humor dynamics in normal human eyes

1 reference

12 December 2020

Separate and combined effects of timolol maleate and acetazolamide in open-angle glaucoma

1 reference

12 December 2020

A Clinical Trial of Metipranolol, a Noncardioselective Beta-Adrenergic Antagonist, in Ocular Hypertension

1 reference

12 December 2020

The mechanism of timolol in lowering intraocular pressure. In the normal eye.

1 reference

12 December 2020

The effect of ocular pigmentation on intraocular pressure response to timolol

1 reference

12 December 2020

Optic nerve head blood flow using a laser Doppler velocimeter and haemorheology in primary open angle glaucoma and normal pressure glaucoma

1 reference

12 December 2020

Betaxolol vs timolol. A six-month double-blind comparison

1 reference

12 December 2020

Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability

1 reference

12 December 2020

[Mid-term results of a double-blind study comparing metipranolol to timolol in the treatment of primary open-angle glaucoma]

1 reference

12 December 2020

The adrenergic receptors of the intraocular muscles of the human eye

1 reference

12 December 2020

Adverse reactions from timolol administration

1 reference

12 December 2020

Metipranolol-associated granulomatous anterior uveitis

1 reference

12 December 2020

Use of betaxolol in the reduction of elevated intraocular pressure

1 reference

12 December 2020

Timolol: short term "escape" and long term "drift"

1 reference

12 December 2020

Effects of brimonidine on aqueous humor dynamics in human eyes

1 reference

12 December 2020

Uniocular miotic therapy

1 reference

12 December 2020

Effects of iris pigmentation on response of ocular pressure to timolol

1 reference

12 December 2020

Retinal Detachments and Topical Ocular Miotics

1 reference

12 December 2020

Pilocarpine. Effect on the anterior chamber and lens thickness

1 reference

12 December 2020

Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans

1 reference

12 December 2020

Timolol-associated myasthenia gravis

1 reference

12 December 2020

Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups.

1 reference

12 December 2020

Metipranolol-associated nongranulomatous anterior uveitis.

1 reference

12 December 2020

Avoiding unsuspected respiratory side-effects of topical timolol with cardioselective or sympathomimetic agents.

1 reference

12 December 2020

Alternative definitions of open-angle glaucoma. Effect on prevalence and associations in the Framingham eye study

1 reference

12 December 2020

Prostaglandin F2 alpha isopropyl ester versus iloprost phenacyl ester in rabbit and beagle eyes

1 reference

12 December 2020

Once-daily versus twice-daily levobunolol (0.5%) therapy. A crossover study.

1 reference

12 December 2020

Black Cornea A Complication of Topical Use of Epinephrine

1 reference

12 December 2020

Effects of topical betaxolol in ocular hypertensive patients

1 reference

12 December 2020

[Comparative multicenter study of carteolol eyedrops with other beta blockers in 768 patients under normal conditions]

1 reference

12 December 2020

Aqueous flow is reduced by the alpha-adrenergic agonist, apraclonidine hydrochloride (ALO 2145)

1 reference

12 December 2020

Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: a review of safety, efficacy, dose response, and dosing studies

1 reference

12 December 2020

[Tachyphylaxis in timolol therapy for chronic glaucoma (author's transl)]

1 reference

12 December 2020

Apraclonidine and timolol. Combined effects in previously untreated normal subjects

1 reference

12 December 2020

Intraocular pressure-reducing effect of PhXA41 in ocular hypertension. Comparison of dose regimens

1 reference

12 December 2020

A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group

1 reference

12 December 2020

The prevalence of glaucoma among Eskimos of northwest Alaska

1 reference

12 December 2020

Laser trabeculoplasty for primary open-angle glaucoma

1 reference

12 December 2020

[Tolerance and pharmacologic effectiveness of antiglaucoma eyedrops]

1 reference

12 December 2020

The safety and efficacy of topical 1% ALO 2145 (p-aminoclonidine hydrochloride) in normal volunteers

1 reference

12 December 2020

A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group

1 reference

12 December 2020

CME and anterior uveitis with latanoprost use.

1 reference

12 December 2020

Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma.

1 reference

12 December 2020

Maintained intraocular pressure reduction with once-a-day application of a new prostaglandin F2 alpha analogue (PhXA41). An in-hospital, placebo-controlled study

1 reference

12 December 2020

Cystoid macular edema associated with latanoprost therapy in a case series of patients with glaucoma and ocular hypertension

1 reference

12 December 2020

Effect of adding betaxolol to dipivefrin therapy

1 reference

12 December 2020

Immediate effect of epinephrine on aqueous formation in the normal human eye as measured by fluorophotometry

1 reference

12 December 2020

The dose response of human intraocular pressure to pilocarpine

1 reference

12 December 2020

Timolol and Myasthenia Gravis

1 reference

12 December 2020

Short-Term Dose Response Characteristics of Acetazolamide in Man

1 reference

12 December 2020

The effect of timolol drops on respiratory function

1 reference

12 December 2020

Long-Term Experience with Timolol Ophthalmic Solution in Patients with Open-Angle Glaucoma

1 reference

12 December 2020

CME and anterior uveitis with latanoprost use

1 reference

12 December 2020

Effect of pilocarpine on visual acuity and on the dimensions of the cornea and anterior chamber

1 reference

12 December 2020

Clinical depression associated with betaxolol

1 reference

12 December 2020

Epinephrine maculopathy

1 reference

12 December 2020

Timolol. A new drug for management of chronic simple glaucoma

1 reference

12 December 2020

'Ocular hypertension' vs open-angle glaucoma: a different view

1 reference

12 December 2020

Iloprost, a stable prostacyclin analog, reduces intraocular pressure

1 reference

12 December 2020

The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975

1 reference

12 December 2020

Prostaglandin-induced iridial pigmentation in primates

1 reference

12 December 2020

Additive effect of betaxolol and epinephrine in primary open angle glaucoma

1 reference

12 December 2020

Uveoscleral drainage of aqueous humour in human eyes

1 reference

12 December 2020

The additive intraocular pressure-lowering effect of latanoprost in combined therapy with other ocular hypotensive agents

1 reference

12 December 2020

Trimolol: effect on intraocular pressure in chronic open-angle glaucoma

1 reference

12 December 2020

Desensitization and redistribution of beta-adrenergic receptors on human mononuclear leukocytes

1 reference

12 December 2020

[Metipranolol 0.1% and pilocarpine 2% as a fixed combination compared to each substance alone in the treatment of glaucoma. A controlled, randomized clinical study comparing the intraindividual effects and tolerance]

1 reference

12 December 2020

Laser Doppler measurement of relative blood velocity in the human optic nerve head

1 reference

12 December 2020

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

1 reference

12 December 2020

Timolol and facility of outflow.

1 reference

12 December 2020

Ca2+ channel-blocking activity of propranolol and betaxolol in isolated bovine retinal microartery

1 reference

12 December 2020

Ocular effects of clonidine in cats and monkeys (Macaca irus)

1 reference

12 December 2020

Additivity of prostaglandin F2 alpha-1-isopropyl ester to timolol in glaucoma patients

1 reference

12 December 2020

Influence of dorzolamide on corneal thickness, endothelial cell count and corneal sensibility.

1 reference

12 December 2020

Black Cornea Secondary to Topical Epinephrine

1 reference

12 December 2020

Long-term evaluation of 0.25% levobunolol and timolol for therapy for elevated intraocular pressure.

1 reference

12 December 2020

Follicular conjunctivitis associated with apraclonidine

1 reference

12 December 2020

A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals

1 reference

12 December 2020

Comparison of two treatment schedules for combined timolol and dipivefrin therapy

1 reference

12 December 2020

Timolol and acetazolamide. A study of concurrent administration

1 reference

12 December 2020

Timolol in the therapy of “ocular hypertension”

1 reference

12 December 2020

Latanoprost and hyperpigmentation of eyelashes.

1 reference

12 December 2020

The relationship between intraocular pressure and visual field progression in glaucoma

1 reference

12 December 2020

Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure.

1 reference

12 December 2020

Penbutolol and carteolol: two new beta-adrenergic blockers with partial agonism

1 reference

12 December 2020

Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients

1 reference

12 December 2020

Therapeutic Index of Pilocarpine, Carbachol, and Timolol With Nasolacrimal Occlusion

1 reference

12 December 2020

Carbonic anhydrase isoenzymes CA I and CA II in the human eye.

1 reference

12 December 2020

Circadian intraocular pressure management with latanoprost: diurnal and nocturnal intraocular pressure reduction and increased uveoscleral outflow.

1 reference

12 December 2020

Metipranolol-induced adverse reactions: I. The rechallenge study

1 reference

12 December 2020

A combination of levobunolol and dipivefrin for the treatment of glaucoma

1 reference

12 December 2020

Intra-ocular pressure, glaucoma, and glaucoma suspects in a defined population

1 reference

12 December 2020

Possible bilateral anterior uveitis secondary to metipranolol (optipranolol) therapy.

1 reference

12 December 2020

[Effect of topical 8-hydroxy carteolol on intraocular pressure and melanin granules]

1 reference

12 December 2020

A clinical trial of timolol and epinephrine in the treatment of primary open-angle glaucoma.

1 reference

12 December 2020

Effects of timolol, epinephrine, and acetazolamide on aqueous flow during sleep.

1 reference

12 December 2020

Bilateral anterior uveitis associated with a brand of metipranolol

1 reference

12 December 2020

A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Dorzolamide-Timolol Combination Study Group.

1 reference

12 December 2020

Epinephrine increases facility of outflow and cyclic AMP content in the human eye in vitro

1 reference

12 December 2020

The mechanism of betaxolol, a new ocular hypotensive agent.

1 reference

12 December 2020

Effectiveness and tolerance of metipranolol--results of a multi-center long-term study in Switzerland

1 reference

12 December 2020

Irreversible corneal decompensation in patients treated with topical dorzolamide

1 reference

12 December 2020

Long-term drift and continued efficacy after multiyear timolol therapy

1 reference

12 December 2020

Clinical efficacy of PhXA34 and PhXA41, two novel prostaglandin F2 alpha-isopropyl ester analogues for glaucoma treatment

1 reference

12 December 2020

Influence of betaxolol and timolol on the visual fields of patients with glaucoma.

1 reference

12 December 2020

Effect on the 24-hour diurnal curve of intraocular pressure of a fixed ratio combination of timolol 0.5% and pilocarpine 2% in patients with COAG not controlled on timolol 0.5%.

1 reference

12 December 2020

Retinal detachment and miotic therapy

1 reference

12 December 2020

Interaction of PhXA41, a new prostaglandin analogue, with pilocarpine. A study on patients with elevated intraocular pressure

1 reference

12 December 2020

Metipranolol-associated granulomatous iritis

1 reference

12 December 2020

Longterm timolol therapy

1 reference

12 December 2020

Argon laser trabeculoplasty controls one third of cases of progressive, uncontrolled, open angle glaucoma for 5 years

1 reference

12 December 2020

Intraocular pressure and the rate of visual field loss in chronic open-angle glaucoma

1 reference

12 December 2020

Intraocular pressure and glaucoma

1 reference

12 December 2020

Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma

1 reference

12 December 2020

Intraocular pressure reduction with PhXA34, a new prostaglandin analogue, in patients with ocular hypertension

1 reference

12 December 2020

Prophylactic use of apraclonidine for intraocular pressure increase after Nd:YAG capsulotomies

1 reference

12 December 2020

The response of ophthalmic arterial pressure to topically applied clonidine

1 reference

12 December 2020

Levobunolol compared with timolol for the long-term control of elevated intraocular pressure

1 reference

12 December 2020

Target pressure in glaucoma therapy.

1 reference

12 December 2020

The global impact of glaucoma

1 reference

12 December 2020

Dose Response Analysis of Pilocarpine-Induced Ocular Hypotension

1 reference

12 December 2020

Fluorescein angiographic evaluation of the effect of latanoprost treatment on blood-retinal barrier integrity: a review of studies conducted on pseudophakic glaucoma patients and on phakic and aphakic monkeys.

1 reference

12 December 2020

Apraclonidine and argon laser trabeculoplasty

1 reference

12 December 2020

Clinical experience with the long-term use of 1% apraclonidine. Incidence of allergic reactions

1 reference

12 December 2020

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

12 December 2020

Respiratory difficulties with betaxolol

1 reference

12 December 2020

Ocular hypertension: to treat or not to treat

1 reference

12 December 2020

Examination methods for glaucoma prevalence surveys

1 reference

12 December 2020

Studies on the effect of Catapresan on the intraocular pressure. 3

1 reference

12 December 2020

Levobunolol and metipranolol: comparative ocular hypotensive efficacy, safety, and comfort

1 reference

12 December 2020

Ocular hypotensive mechanism of topical isopropyl unoprostone, a novel prostaglandin metabolite-related drug, in rabbits

1 reference

12 December 2020

Production and drainage of aqueous humor in the cynomolgus monkey (Macaca irus)

1 reference

12 December 2020

Cystoid macular edema associated with latanoprost in aphakic and pseudophakic eyes.

1 reference

12 December 2020

Double-masked comparative study of UF-021 and timolol ophthalmic solutions in patients with primary open-angle glaucoma or ocular hypertension

1 reference

12 December 2020

The efficacy and safety of dorzolamide as adjunctive therapy to timolol maleate gellan solution in patients with elevated intraocular pressure. Additivity Study Group

1 reference

12 December 2020

Preclinical evaluation of brimonidine

1 reference

12 December 2020

Aqueous humor flow measured by fluorophotometry. A comparative study of the effect of various beta-blocker eyedrops in patients with ocular hypertension

1 reference

12 December 2020

Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985.

1 reference

12 December 2020

Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month study

1 reference

12 December 2020

Evaluation of Timolol Maleate Combination Therapy in Chronic Open-Angle Glaucoma

1 reference

12 December 2020

Effects of Topical Betaxolol, Timolol, and Placebo on Pulmonary Function in Asthmatic Bronchitis

1 reference

12 December 2020

Diamox (acetazoleamide) in treatment of glaucoma

1 reference

12 December 2020

Levobunolol. A beta-adrenoceptor antagonist effective in the long-term treatment of glaucoma. The Levobunolol Study Group (Appended)

1 reference

12 December 2020

Short-term Effects of Unilateral 1% Apraclonidine Therapy

1 reference

12 December 2020

Clonidine. Effects of a topically administered solution on intraocular pressure and blood pressure in open-angle glaucoma

1 reference

12 December 2020

Fluorophotometric study of epinephrine and timolol in human subjects

1 reference

12 December 2020

DOSE-EFFECT RELATIONSHIPS AS AN AID IN THE EVALUATION OF OCULAR HYPOTENSIVE DRUGS

1 reference

12 December 2020

Adverse events of anti-glaucoma beta-blockers: presentation of an original HPLC determination procedure

1 reference

12 December 2020

Effects of topical application of UF-021, a novel prostaglandin-related compound, on aqueous humor dynamics in rabbit

1 reference

12 December 2020

'Glaucoma suspect' or 'ocular hypertension'

1 reference

12 December 2020

Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, diamox; a preliminary report

1 reference

12 December 2020

Effect of 2% levo-rotary epinephrine on the intraocular pressure of the glaucomatous eye

1 reference

12 December 2020

Interim report: National Registry of possible Drug-induced Ocular Side Effects

1 reference

12 December 2020

[Four new drugs for glaucoma: apraclonidine, brimonidine, dorzolamide and latanoprost]

1 reference

12 December 2020

Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma

1 reference

12 December 2020

Blind randomised non-crossover long-term trial comparing topical timolol 0.25% with timolol 0.5% in the treatment of simple chronic glaucoma

1 reference

12 December 2020

A double-masked, randomized, 1-year study comparing the corneal effects of dorzolamide, timolol, and betaxolol. Dorzolamide Corneal Effects Study Group

1 reference

12 December 2020

A double-masked comparison of carteolol and timolol in ocular hypertension

1 reference

12 December 2020

Efficacy of combining timolol with other antiglaucoma medications

1 reference

12 December 2020

Ocular hypotensive efficacy of 0.25% levobunolol instilled once daily.

1 reference

12 December 2020

Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost

1 reference

12 December 2020

Topical beta-blocker therapy and central nervous system side effects. A preliminary study comparing betaxolol and timolol

1 reference

12 December 2020

Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure

1 reference

12 December 2020

The dose-response relationships of dipivalyl epinephrine in open-angle glaucoma

1 reference

12 December 2020

Levobunolol. A four-year study of efficacy and safety in glaucoma treatment. The Levobunolol Study Group

1 reference

12 December 2020

Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2.

1 reference

12 December 2020

Acute angle closure glaucoma: relative failure of YAG iridotomy in affected eyes and factors influencing outcome

1 reference

12 December 2020

Effect of dorzolamide on corneal endothelial function in normal human eyes.

1 reference

12 December 2020

Betaxolol and restrictive airway disease. Case report

1 reference

12 December 2020

Reduction of intraocular pressure by prostaglandins applied topically to the eyes of conscious rabbits

1 reference

12 December 2020

Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy

1 reference

12 December 2020

Adverse effects experienced by patients taking timolol

1 reference

12 December 2020

Systemic effects of three beta-blocker eyedrops: comparison in healthy volunteers of beta 1- and beta 2-adrenoreceptor inhibition

1 reference

12 December 2020

Beta 1- and beta 2-antagonist activity of topically applied betaxolol and timolol in the systemic circulation

1 reference

12 December 2020

Dipivefrin and epinephrine treatment of elevated intraocular pressure: a comparative study

1 reference

12 December 2020

Experimental aqueous perfusion in enucleated human eyes

1 reference

12 December 2020

A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study

1 reference

12 December 2020

Timolol: Its Effectiveness in Different Types of Glaucoma

1 reference

12 December 2020

Cystoid macular edema associated with topically applied epinephrine in aphakic eyes

1 reference

12 December 2020

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

1 reference

12 December 2020

Comparison of apraclonidine and timolol in chronic open-angle glaucoma. A three-month study

1 reference

12 December 2020

Experiences with timolol in treatment of glaucoma (author's transl)

1 reference

12 December 2020

The efficacy of apraclonidine as an adjunct to timolol therapy. Apraclonidine Adjunctive Therapy Study Group.

1 reference

12 December 2020

The Effects of Dipivalyl Epinephrine on the Eye

1 reference

12 December 2020

Effects of timolol maleate on tear flow in human eyes

1 reference

12 December 2020

Alpha 2-adrenergic agonists induce basic fibroblast growth factor expression in photoreceptors in vivo and ameliorate light damage.

1 reference

12 December 2020

Color Doppler imaging and spectral analysis of the optic nerve vasculature in glaucoma

1 reference

12 December 2020

Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes

1 reference

12 December 2020

Effects of apraclonidine on aqueous humor dynamics in human eyes

1 reference

12 December 2020

Long-term effect of ophthalmic beta-adrenoceptor antagonists on intraocular pressure and retinal sensitivity in primary open-angle glaucoma

1 reference

12 December 2020

Adrenergic and adrenolytic effects on intraocular pressure

1 reference

12 December 2020

Residual pilocarpine effects on outflow facility after ciliary muscle disinsertion in the synomolgus monkey

1 reference

12 December 2020

The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye color.

1 reference

12 December 2020

Rate of progression in open-angle glaucoma estimated from cross-sectional prevalence of visual field damage

1 reference

12 December 2020

Evaluation of once-daily levobunolol 0.25% and timolol 0.25% therapy for increased intraocular pressure

1 reference

12 December 2020

MK-507 (L-671,152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys

1 reference

12 December 2020

Effects of ocular carteolol and timolol on plasma high-density lipoprotein cholesterol level

1 reference

12 December 2020

Decreased intraocular pressure in the hypertensive human eye with betaxolol, a beta 1-adrenergic antagonist.

1 reference

12 December 2020

A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The Brimonidine Study Group III

1 reference

12 December 2020

The effect of adding prostaglandin F2 alpha-isopropylester to timolol in patients with open angle glaucoma

1 reference

12 December 2020

The lack of respiratory effects of the ocular hypotensive drug latanoprost in patients with moderate-steroid treated asthma

1 reference

12 December 2020

Brimonidine tartrate: a one-month dose response study

1 reference

12 December 2020

The pathogenesis of the glaucoma field: clinical evidence that circulatory insufficiency in the optic nerve is the primary cause of visual field loss in glaucoma

1 reference

12 December 2020

Intraocular pressure response to replacing pilocarpine with carbachol.

1 reference

12 December 2020

Effect of clonidine on intraocular pressure and pupil diameter

1 reference

12 December 2020

The effect of topical ophthalmic instillation of timolol and betaxolol on lung function in asthmatic subjects

1 reference

12 December 2020

Ophthalmic timolol treatment causing altered hypoglycemic response in a diabetic patient.

1 reference

12 December 2020

Effect of clonidine on aqueous humor flow in normal human eyes

1 reference

12 December 2020

The relaxant action of betaxolol on isolated bovine retinal microarteries

1 reference

12 December 2020

A 3-month comparison of 1% and 2% carteolol and 0.5% timolol in open-angle glaucoma

1 reference

12 December 2020

Timolol—Further Observations

1 reference

12 December 2020

Comparative studies of initial pressure reduction using 0.3% metipranolol and 0.25% timolol in eyes with wide-angle glaucoma

1 reference

12 December 2020

Pilocarpine antagonizes prostaglandin F2 alpha-induced ocular hypotension in monkeys. Evidence for enhancement of Uveoscleral outflow by prostaglandin F2 alpha

1 reference

12 December 2020

Levobunolol compared with timolol: a four-year study

1 reference

12 December 2020

Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group

1 reference

12 December 2020

Correlation of Epinephrine Use and Macular Edema in Aphakic Glaucomatous Eyes

1 reference

12 December 2020

Conjunctival melanin depositions. A side-effect of topical epinephrine therapy

1 reference

12 December 2020

Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension

1 reference

12 December 2020

The Relevance of Intrinsic Sympathomimetic Activity for β-Blocker-Induced Changes in Plasma Lipids

1 reference

12 December 2020

Topical epinephrine therapy of open-angel glaucoma.

1 reference

12 December 2020

The effect of 1.5% timolol maleate on intraocular pressure

1 reference

12 December 2020

Early postmarketing surveillance of betaxolol hydrochloride, September 1985-September 1986

1 reference

12 December 2020

Low-dose epinephrine.

1 reference

12 December 2020

Latanoprost-associated cystoid macular edema

1 reference

12 December 2020

Effects of atropine and pilocarpine on aqueous humour dynamics in cynomolgus monkeys (Macaca irus).

1 reference

12 December 2020

Early Effect of Epinephrine on Aqueous Formation in the Normal Human Eye

1 reference

12 December 2020

Scanning electron microscopic studies of the trabecular meshwork and the canal of Schlemm--an attempt to localize the main resistance to outflow of aqueous humor in man.

1 reference

12 December 2020

The effects of timolol maleate and acetazolamide on the rate of aqueous formation in normal human subjects

1 reference

12 December 2020

Papillary circulation dynamics in glaucoma.

1 reference

12 December 2020

Ophthalmic artery flow velocity in glaucomatous and normal subjects

1 reference

12 December 2020

A double-masked study of timolol and pilocarpine combined.

1 reference

12 December 2020

Propranolol as ocular hypotensive agent

1 reference

12 December 2020

Ocular metipranolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in glaucoma and ocular hypertension

1 reference

12 December 2020

Loss of acute pilocarpine effect on outflow facility following surgical disinsertion and retrodisplacement of the ciliary muscle from the scleral spur in the cynomolgus monkey

1 reference

12 December 2020

Morphologic changes in the lamina cribrosa correlated with neural loss in open-angle glaucoma

1 reference

12 December 2020

Cardiovascular and intraocular pressure effects and plasma concentrations of apraclonidine

1 reference

12 December 2020

The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group

1 reference

12 December 2020

Anterior uveitis associated with latanoprost

1 reference

12 December 2020

Congestive heart failure from betaxolol. Case report.

1 reference

12 December 2020

Adrenochrome pigmentation

1 reference

12 December 2020

Effect of timolol therapy on outflow facility

1 reference

12 December 2020

Effects of apraclonidine on intraocular pressure and blood-aqueous barrier permeability after phacoemulsification and intraocular lens implantation

1 reference

12 December 2020

10.2165/00003495-200059030-00003

Identifiers

DOI

1 reference

PubMed ID

10776828

Dimensions Publication ID

27 June 2017

0 references

1 reference

PubMed ID

10776828